SRRK
Scholar Rock Holding Corporation
NASDAQ · Healthcare · Biotechnology · US
$55.33
−1.09%Leverage
- Debt / equity
- 0.80x
- Net debt / equity
- -0.92x
- Debt / assets
- 0.39x
- Debt / EBITDA
- -0.51x
- Net debt / EBITDA
- 0.59x
Liquidity & coverage
- Current ratio
- 7.02x
- Quick ratio
- 7.02x
- Cash ratio
- 6.81x
- Interest coverage
- -38.02x
- EBITDA / interest
- -37.09x
- Working capital
- $434.9M
Cash & dividend
- FCF / debt
- -1.45x
- Cash flow / debt
- -1.45x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026